Literature DB >> 18587088

Routine quality control of clinical nuclear medicine instrumentation: a brief review.

Pat Zanzonico1.   

Abstract

This article reviews routine quality-control (QC) procedures for current nuclear medicine instrumentation, including the survey meter, dose calibrator, well counter, intraoperative probe, organ ("thyroid") uptake probe, gamma-camera, SPECT and SPECT/CT scanner, and PET and PET/CT scanner. It should be particularly useful for residents, fellows, and other trainees in nuclear medicine, nuclear cardiology, and radiology. The procedures described and their respective frequencies are presented only as general guidelines.

Entities:  

Mesh：

Year:  2008        PMID： 18587088      PMCID： PMC2703015          DOI： 10.2967/jnumed.107.050203

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  The intraoperative gamma probe: basic principles and choices available.

Authors:  P Zanzonico; S Heller
Journal:  Semin Nucl Med       Date:  2000-01       Impact factor: 4.446

Review 2.  Radiation dose in computed tomography of the heart.

Authors:  Richard L Morin; Thomas C Gerber; Cynthia H McCollough
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

Review 3.  Physics and dosimetry in computed tomography.

Authors:  Richard L Morin; Thomas C Gerber; Cynthia H McCollough
Journal:  Cardiol Clin       Date:  2003-11       Impact factor: 2.213

Review 4.  PET/CT scanners: a hardware approach to image fusion.

Authors:  David W Townsend; Thomas Beyer; Todd M Blodgett
Journal:  Semin Nucl Med       Date:  2003-07       Impact factor: 4.446

Review 5.  Positron emission tomography: a review of basic principles, scanner design and performance, and current systems.

Authors:  Pat Zanzonico
Journal:  Semin Nucl Med       Date:  2004-04       Impact factor: 4.446

Review 6.  Techniques and parameters for estimating radiation exposure and dose in cardiac computed tomography.

Authors:  Thomas C Gerber; Ronald S Kuzo; Richard L Morin
Journal:  Int J Cardiovasc Imaging       Date:  2005-02       Impact factor: 2.357

7.  Instrumentation quality assurance and performance.

Authors:  Kenneth J Nichols; Stephen L Bacharach; Steven R Bergmann; S James Cullom; Edward P Ficaro; James R Galt; Gary V Heller; Jonathan Links; Josef Machac
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

8.  Quantitation in positron emission computed tomography: 1. Effect of object size.

Authors:  E J Hoffman; S C Huang; M E Phelps
Journal:  J Comput Assist Tomogr       Date:  1979-06       Impact factor: 1.826

9.  Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee.

Authors:  L S Graham; F H Fahey; M T Madsen; A van Aswegen; M V Yester
Journal:  Med Phys       Date:  1995-04       Impact factor: 4.071
  9 in total
  27 in total

1.  Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.

Authors:  Jason P Holland; Guillaume Normand; Alessandro Ruggiero; Jason S Lewis; Jan Grimm
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

2.  Acceptance testing for nuclear medicine instrumentation.

Authors:  Ellinor Busemann Sokole; Anna Płachcínska; Alan Britten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03       Impact factor: 9.236

3.  Routine quality control recommendations for nuclear medicine instrumentation.

Authors:  Ellinor Busemann Sokole; Anna Płachcínska; Alan Britten; Maria Lyra Georgosopoulou; Wendy Tindale; Rigobert Klett
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03       Impact factor: 9.236

4.  Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.

Authors:  Sibaprasad Bhattacharyya; Karen Kurdziel; Ling Wei; Lisa Riffle; Gurmeet Kaur; G Craig Hill; Paula M Jacobs; James L Tatum; James H Doroshow; Joseph D Kalen
Journal:  Nucl Med Biol       Date:  2013-02-27       Impact factor: 2.408

5.  Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor.

Authors:  Simon Klingler; Rachael Fay; Jason P Holland
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

6.  Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy.

Authors:  Ling Wei; Jianfeng Shi; George Afari; Sibaprasad Bhattacharyya
Journal:  J Labelled Comp Radiopharm       Date:  2013-11-13       Impact factor: 1.921

7.  First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer.

Authors:  Jens Kurth; Bernd Joachim Krause; Sarah M Schwarzenböck; Carina Bergner; Oliver W Hakenberg; Martin Heuschkel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-03       Impact factor: 9.236

8.  Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.

Authors:  Darrin Byrd; Rebecca Christopfel; Grae Arabasz; Ciprian Catana; Joel Karp; Martin A Lodge; Charles Laymon; Eduardo G Moros; Mikalai Budzevich; Sadek Nehmeh; Joshua Scheuermann; John Sunderland; Jun Zhang; Paul Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-04

9.  Design and performance of the micro-dose calibrator.

Authors:  Stephen Adler; Peter Choyke
Journal:  Phys Med Biol       Date:  2018-09-10       Impact factor: 3.609

10.  Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.

Authors:  Jason P Holland; Eloisi Caldas-Lopes; Vadim Divilov; Valerie A Longo; Tony Taldone; Danuta Zatorska; Gabriela Chiosis; Jason S Lewis
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.